• Media type: E-Article
  • Title: Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study
  • Contributor: Burger, Robert Allen; Enserro, Danielle; Tewari, Krishnansu Sujata; Brady, Mark F.; Bookman, Michael A.; Fleming, Gini F.; Huang, Helen Q; Homesley, Howard D.; Fowler, Jeffrey; Boente, Matthew; Randall, Leslie M.; Chan, John K.; Ferris, James Stuart; DiSaia, Philip J.; Copeland, Larry J.; Mannel, Robert S.; Birrer, Michael J.; Monk, Bradley J.
  • imprint: American Society of Clinical Oncology (ASCO), 2018
  • Published in: Journal of Clinical Oncology, 36 (2018) 15_suppl, Seite 5517-5517
  • Language: English
  • DOI: 10.1200/jco.2018.36.15_suppl.5517
  • ISSN: 0732-183X; 1527-7755
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Access State: Open Access